Patel et al. treated TCCSUP cells with atypical PKC inhibitors and rapamycin and reported attenuated viability of BC cells [52].Their study suggested that mTOR pathway plays a role in PKCs activation and also suggested a possible combined therapeutic approach for BC. The gene discussed is PRRT2; the disease is breast cancer.